SCHEMBL4925192

SCHEMBL4925192

CCCCC(CC)CC(NC(=O)NC(=O)c1ccccc1)c1ccc(C=CC(=O)NO)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
HDAC3 O15379 11/20 0.42
HDAC2 Q92769 11/20 0.42
HDAC4 P56524 10/20 0.42
HDAC1 Q13547 10/20 0.42
HDAC8 Q9BY41 10/20 0.42
HDAC6 Q9UBN7 10/20 0.42
HDAC7 Q8WUI4 9/20 0.42
HDAC10 Q969S8 9/20 0.42
HDAC11 Q96DB2 9/20 0.42
HDAC9 Q9UKV0 9/20 0.42
HDAC5 Q9UQL6 9/20 0.42
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
UTS2R Q9UKP6 3/20 0.40
EGFR P00533 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932493 0.87 EGFR (0.47) HDAC3HDAC2HDAC4HDAC1HDAC8
SCHEMBL4922709 0.84 HDAC2 (0.49) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4928501 0.83 HDAC1 (0.50) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4929939 0.82 HDAC1 (0.49) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4930697 0.80 HDAC1 (0.52) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4929990 0.80 HDAC1 (0.49) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4931664 0.80 UTS2R (0.51) HDAC3HDAC2HDAC4HDAC1HDAC8
SCHEMBL4931762 0.79 HDAC1 (0.51) LMNAHDAC3HDAC2HDAC4HDAC1
SCHEMBL4925750 0.79 UTS2R (0.64) UTS2R
SCHEMBL4933486 0.79 HDAC2 (0.50) LMNAHDAC3HDAC2HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 LMNA 2840/4885HDAC3 2/4885HDAC2 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.